Healthy Heart Africa

Strengthening healthcare capabilities.

Healthy Heart Africa (HHA) is our innovative programme committed to tackling hypertension (high blood pressure) and the increasing burden of cardiovascular disease (CVD) in Africa.

According to estimates from 2012, over three quarters of premature deaths were caused by cardiovascular disease, cancer, diabetes and chronic respiratory disease.

HHA aims to reach 10 million hypertensive patients across Africa by 2025. To achieve this we are supporting local health systems by increasing awareness of the symptoms and risks of hypertension and by offering education, screening, reduced-cost treatment and control. In developing a programme to address hypertension in Africa, we realised that we needed to customise our approach to suit conditions on the ground.

Recognising the significant barriers to access, HHA’s model is based on three key pillars:

  • Increasing education and awareness;
  • Training providers and supporting the development of guidelines that are appropriate for community-based implementation;
  • Developing a supply chain and distribution model that ensures access and affordability.

To build local capacity, we joined forces with six local partners across the private, public and faith-based sectors in Kenya at every level of care, to create a demonstration model that works for the country. We also collaborate with Kenya’s Mission for Essential Drugs and Supplies (MEDS), to establish secure supply chains for anti-hypertensive medicines, and with Savannah, a Kenyan data management company, to allow for continuous monitoring of programme outputs and patient level data capture.



Healthy Heart Africa achievements

Healthy Heart Africa aims to reach 10 million hypertensive patients across Africa by 2025.

Since launching HHA in 2014, we have:

  • Conducted over 2.7 million hypertension screenings
  • Activated over 404 health facilities
  • Trained over 3,000 healthcare workers across 31 counties
  • Diagnosed over 300,000 patients with high blood pressure
  • Started treatment for 100,000 patients.